MARCHF5 and neoplasm: Significantly, while the MARCH5 mediated degradation of MCL1 markedly sensitized tumor cells to BCLXL inhibition, MARCH5 depletion, which occurs in ~5% of PCa, also sensitized to BCLXL inhibition despite increased MCL1, revealing a codependency between MCL1 and MARCH5.